A patient is experiencing symptoms of ototoxicity and is currently on medication. Which combination of medications is most likely contributing to this condition.

Choice A rationale Beta-blockers and ACE inhibitors are primary cardiovascular medications used to manage hypertension and heart failure. Beta-blockers decrease heart rate and contractility, while ACE inhibitors prevent the conversion of angiotensin I to angiotensin II to promote vasodilation. Neither of these drug classes is traditionally associated with ototoxicity, which involves damage to the inner ear structures. Their side effect profiles typically involve bradycardia, hypotension, or a dry cough, rather than hearing loss or tinnitus. Choice B rationale The combination of loop diuretics, like furosemide, and aminoglycosides, like gentamicin, significantly increases the risk of ototoxicity. Loop diuretics can alter the electrolyte composition of the endolymph in the inner ear, while aminoglycosides cause direct biochemical damage to the hair cells in the cochlea. When used together, their effects are often synergistic, leading to permanent or temporary hearing loss and vestibular dysfunction. Normal serum gentamicin levels are typically a peak of 5 to 10 mcg/mL. Choice C rationale NSAIDs, specifically high-dose aspirin, can cause reversible tinnitus and hearing loss by interfering with prostaglandin synthesis and cochlear blood flow. Anticoagulants like heparin or warfarin affect the clotting cascade to prevent thrombus formation. While aspirin has ototoxic potential in high doses, anticoagulants do not typically target the auditory system. This combination is less commonly associated with the specific clinical presentation of medication-induced ototoxicity compared to the potent combination of loop diuretics and aminoglycoside antibiotics. Choice D rationale Calcium channel blockers are used to manage blood pressure and arrhythmias by inhibiting the influx of calcium ions into cardiac and smooth muscle cells. Statins are HMG-CoA reductase inhibitors used to lower cholesterol levels. Neither of these drug classes is linked to the destruction of auditory nerves or the sensory hair cells of the inner ear. Their common adverse effects include peripheral edema or myalgia, making them an unlikely cause for the symptoms of ototoxicity.